Current guidance was classified as lowered.
Low confidenceEarnings filing (8-K) · Latest 10-Q filings
Last updated: Aug 25, 2026 at 4:37 AM UTC
Weakened
Legacy analysis: only the dimensions classifiable by the pre-v1 pipeline are shown.
- Legacy analysis: scored by the pre-v1 pipeline; deep evidence has not been re-verified.
Reported facts
GAAP facts are reported by the company. Comparable figures are EarnIQ arithmetic using only quantified adjustments disclosed in the linked SEC exhibit.
Reported EPS and revenue have not yet been extracted from the filing.
Earnings quality
From 10-Q / 10-K XBRL filings. Sloan (1996) accruals: high accruals relative to assets have historically preceded earnings disappointments. Descriptive research, not a prediction.
Depreciation is disclosed annually by most filers, so quarterly values blend actuals with estimates — flagged on every reading. Method: TTM Sloan accruals ÷ average assets, scored 1–5 by quintile.
1. Three decisive changes
Largest quantified changes versus the company's own history.
$1.3B vs $1.0B a year ago · quarter ended Jun 30, 2026 · from 10-Q XBRL filings.
$785.0M vs $637.0M a year ago · quarter ended Jun 30, 2026 · from 10-Q XBRL filings.
$6.7B vs $6.0B a year ago · quarter ended Jun 30, 2026 · from 10-Q XBRL filings.
2. Was it already expected?
Consensus classifications require timestamped pre-report snapshots and eight-quarter surprise history.
| Item | Actual | Expected | Gap | Class |
|---|---|---|---|---|
| Consensus comparison coming soon. | ||||
3. Management consistency
Only attributable, measurable and dated commitments are counted. Delivery record: Not available.
| Promise | Target | Outcome | Status | Evidence |
|---|---|---|---|---|
| No measurable, dated management promises have been verified for this record. | ||||
4. What matters next
One deciding measurable condition plus up to two supporting checkpoints.
Revenue guidance was lowered slightly by about 0.6% to a range of $26.275 to $26.475 billion, while full-year adjusted operating EBITDA was maintained between $8.15 and $8.25 billion.
5. Risks that changed
New or materially worsened items only; unchanged boilerplate is omitted.
FY2025 10-K vs prior year, boilerplate filtered out — these are idiosyncratic changes, and tone is slightly less negative.
New risk disclosure #1
“The decline in market prices in 2025 for recyclable commodities resulted in a year-over-year decrease in revenue of $166 million, and 29…”
New risk disclosure #2
“Table of Contents the introduction of new technology and other initiatives, which can result in increased operating expenses and lower net income. If we are unable to negotiate acceptable collective bargaining agreements…”
New risk disclosure #3
“At the time of our acquisition of Stericycle, it was, and had been, involved in certain government investigations, enforcement proceedings, lawsuits and other disputes alleging noncompliance with applicable regulations, …”
6. Evidence drawer
Source location, short anchor and visible arithmetic for every verified claim.
Operating income: +23.7% year over year
(1,253,000,000 − 1,013,000,000) ÷ 1,013,000,000 = +23.7% YoYNet income: +23.2% year over year
(785,000,000 − 637,000,000) ÷ 637,000,000 = +23.2% YoYRevenue: +11.1% year over year
(6,684,000,000 − 6,018,000,000) ÷ 6,018,000,000 = +11.1% YoY